Literature DB >> 19416821

Catalytically-active complex of HIV-1 integrase with a viral DNA substrate binds anti-integrase drugs.

Akram Alian1, Sarah L Griner, Vicki Chiang, Manuel Tsiang, Gregg Jones, Gabriel Birkus, Romas Geleziunas, Andrew D Leavitt, Robert M Stroud.   

Abstract

HIV-1 integration into the host cell genome is a multistep process catalyzed by the virally-encoded integrase (IN) protein. In view of the difficulty of obtaining a stable DNA-bound IN at high concentration as required for structure determination, we selected IN-DNA complexes that form disulfide linkages between 5'-thiolated DNA and several single mutations to cysteine around the catalytic site of IN. Mild reducing conditions allowed for selection of the most thermodynamically-stable disulfide-linked species. The most stable complexes induce tetramer formation of IN, as happens during the physiological integration reaction, and are able to catalyze the strand transfer step of retroviral integration. One of these complexes also binds strand-transfer inhibitors of HIV antiviral drugs, making it uniquely valuable among the mutants of this set for understanding portions of the integration reaction. This novel complex may help define substrate interactions and delineate the mechanism of action of known integration inhibitors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19416821      PMCID: PMC2688900          DOI: 10.1073/pnas.0811919106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity.

Authors:  J Greenwald; V Le; S L Butler; F D Bushman; S Choe
Journal:  Biochemistry       Date:  1999-07-13       Impact factor: 3.162

2.  Large-scale conformational dynamics of the HIV-1 integrase core domain and its catalytic loop mutants.

Authors:  Matthew C Lee; Jinxia Deng; James M Briggs; Yong Duan
Journal:  Biophys J       Date:  2005-02-24       Impact factor: 4.033

3.  Relationship between the oligomeric status of HIV-1 integrase on DNA and enzymatic activity.

Authors:  Elvire Guiot; Kevin Carayon; Olivier Delelis; Françoise Simon; Patrick Tauc; Evgenii Zubin; Marina Gottikh; Jean-François Mouscadet; Jean-Claude Brochon; Eric Deprez
Journal:  J Biol Chem       Date:  2006-06-13       Impact factor: 5.157

4.  Retroviral DNA integration: reaction pathway and critical intermediates.

Authors:  Min Li; Michiyo Mizuuchi; Terrence R Burke; Robert Craigie
Journal:  EMBO J       Date:  2006-02-16       Impact factor: 11.598

5.  Identification of amino acids in HIV-1 and avian sarcoma virus integrase subsites required for specific recognition of the long terminal repeat Ends.

Authors:  Aiping Chen; Irene T Weber; Robert W Harrison; Jonathan Leis
Journal:  J Biol Chem       Date:  2005-11-18       Impact factor: 5.157

6.  A three-dimensional model of the human immunodeficiency virus type 1 integration complex.

Authors:  Jerome Wielens; Ian T Crosby; David K Chalmers
Journal:  J Comput Aided Mol Des       Date:  2005-05       Impact factor: 3.686

7.  Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrases.

Authors:  S Maignan; J P Guilloteau; Q Zhou-Liu; C Clément-Mella; V Mikol
Journal:  J Mol Biol       Date:  1998-09-18       Impact factor: 5.469

8.  Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking.

Authors:  T M Jenkins; D Esposito; A Engelman; R Craigie
Journal:  EMBO J       Date:  1997-11-17       Impact factor: 11.598

9.  Small-angle X-ray characterization of the nucleoprotein complexes resulting from DNA-induced oligomerization of HIV-1 integrase.

Authors:  Svetlana Baranova; Fedor V Tuzikov; Olga D Zakharova; Natalia A Tuzikova; Christina Calmels; Simon Litvak; Laura Tarrago-Litvak; Vincent Parissi; Georgy A Nevinsky
Journal:  Nucleic Acids Res       Date:  2007-01-26       Impact factor: 16.971

10.  HIV-1 integrase crosslinked oligomers are active in vitro.

Authors:  Aurélie Faure; Christina Calmels; Cécile Desjobert; Michel Castroviejo; Anne Caumont-Sarcos; Laura Tarrago-Litvak; Simon Litvak; Vincent Parissi
Journal:  Nucleic Acids Res       Date:  2005-02-17       Impact factor: 16.971

View more
  21 in total

1.  Scaffold rearrangement of dihydroxypyrimidine inhibitors of HIV integrase: Docking model revisited.

Authors:  Jing Tang; Kasthuraiah Maddali; Yves Pommier; Yuk Y Sham; Zhengqiang Wang
Journal:  Bioorg Med Chem Lett       Date:  2010-04-21       Impact factor: 2.823

2.  HIV-1 integrase sequence variability in antiretroviral naïve patients and in triple-class experienced patients subsequently treated with raltegravir.

Authors:  Vici Varghese; Tommy F Liu; Soo-Yon Rhee; Paolo Libiran; Christina Trevino; W Jeffrey Fessel; Robert W Shafer
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-21       Impact factor: 2.205

3.  The Preserved HTH-Docking Cleft of HIV-1 Integrase Is Functionally Critical.

Authors:  Meytal Galilee; Elena Britan-Rosich; Sarah L Griner; Serdar Uysal; Viola Baumgärtel; Don C Lamb; Anthony A Kossiakoff; Moshe Kotler; Robert M Stroud; Ailie Marx; Akram Alian
Journal:  Structure       Date:  2016-09-29       Impact factor: 5.006

Review 4.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

5.  Structure-based modeling of the functional HIV-1 intasome and its inhibition.

Authors:  Lavanya Krishnan; Xiang Li; Hema L Naraharisetty; Stephen Hare; Peter Cherepanov; Alan Engelman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

6.  Strain-specific effect on biphasic DNA binding by HIV-1 integrase.

Authors:  Kyle J Hill; Leonard C Rogers; Duncan T Njenda; Donald H Burke; Stefan G Sarafianos; Anders Sönnerborg; Ujjwal Neogi; Kamalendra Singh
Journal:  AIDS       Date:  2019-03-01       Impact factor: 4.177

Review 7.  HIV resistance to raltegravir.

Authors:  Francois Clavel
Journal:  Eur J Med Res       Date:  2009-11-24       Impact factor: 2.175

8.  Structural properties of HIV integrase. Lens epithelium-derived growth factor oligomers.

Authors:  Kushol Gupta; Tracy Diamond; Young Hwang; Frederic Bushman; Gregory D Van Duyne
Journal:  J Biol Chem       Date:  2010-04-20       Impact factor: 5.157

9.  Retroviral intasome assembly and inhibition of DNA strand transfer.

Authors:  Stephen Hare; Saumya Shree Gupta; Eugene Valkov; Alan Engelman; Peter Cherepanov
Journal:  Nature       Date:  2010-01-31       Impact factor: 49.962

10.  The HIV-1 integrase mutations Y143C/R are an alternative pathway for resistance to Raltegravir and impact the enzyme functions.

Authors:  Sandrine Reigadas; Guerric Anies; Bernard Masquelier; Christina Calmels; Lieven J Stuyver; Vincent Parissi; Herve Fleury; Marie-Line Andreola
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.